Monday, December 1, 2008 - 12:49PM EST

United States

Massachusetts

Name of AuthorInstitutional Affiliation
Alyea EP 3rdDivision of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Anderson KDana-Farber Cancer Institute, Boston, MA, USA.
Ghobrial IMJerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA. irene_ghobrial@dfci.harvard.edu
Hwang JJHarvard Medical School, Boston, MA, USA.
Koreth JDivision of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. John.Koreth@dfci.harvard.edu
Raje NDivision of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. nraje@partners.org
Richardson PJerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
Pages: 1 2
Next: Michigan